160 related articles for article (PubMed ID: 3031541)
1. Kappa opioid receptor activation depresses excitatory synaptic input to rat locus coeruleus neurons in vitro.
McFadzean I; Lacey MG; Hill RG; Henderson G
Neuroscience; 1987 Jan; 20(1):231-9. PubMed ID: 3031541
[TBL] [Abstract][Full Text] [Related]
2. A highly selective kappa-opioid receptor agonist, CI-977, reduces excitatory synaptic potentials in the rat locus coeruleus in vitro.
Pinnock RD
Neuroscience; 1992; 47(1):87-94. PubMed ID: 1315940
[TBL] [Abstract][Full Text] [Related]
3. Activation of kappa-opioid receptors depresses electrically evoked excitatory postsynaptic potentials on 5-HT-sensitive neurones in the rat dorsal raphé nucleus in vitro.
Pinnock RD
Brain Res; 1992 Jun; 583(1-2):237-46. PubMed ID: 1354563
[TBL] [Abstract][Full Text] [Related]
4. Different profile of electrocortical power spectrum changes after micro-infusion into the locus coeruleus of selective agonists at various opioid receptor subtypes in rats.
Bagetta G; De Sarro GB; Sakurada S; Rispoli V; Nisticò G
Br J Pharmacol; 1990 Nov; 101(3):655-61. PubMed ID: 1963804
[TBL] [Abstract][Full Text] [Related]
5. Opioid-glutamate interactions in rat locus coeruleus neurons.
Oleskevich S; Clements JD; Williams JT
J Neurophysiol; 1993 Sep; 70(3):931-7. PubMed ID: 7693886
[TBL] [Abstract][Full Text] [Related]
6. Enkephalins modulate excitatory synaptic transmission in the superficial dorsal horn by acting at mu-opioid receptor sites.
Jeftinija S
Brain Res; 1988 Sep; 460(2):260-8. PubMed ID: 2852045
[TBL] [Abstract][Full Text] [Related]
7. Opioid peptides reduce synaptic transmission in the nucleus accumbens.
Yuan XR; Madamba S; Siggins GR
Neurosci Lett; 1992 Jan; 134(2):223-8. PubMed ID: 1317025
[TBL] [Abstract][Full Text] [Related]
8. Kappa and delta opioid receptor stimulation affects cardiac myocyte function and Ca2+ release from an intracellular pool in myocytes and neurons.
Ventura C; Spurgeon H; Lakatta EG; Guarnieri C; Capogrossi MC
Circ Res; 1992 Jan; 70(1):66-81. PubMed ID: 1309318
[TBL] [Abstract][Full Text] [Related]
9. Bremazocine differentially antagonizes responses to selective mu and delta opioid receptor agonists in rat hippocampus.
Dunwiddie TV; Johnson KJ; Proctor WR
Br J Pharmacol; 1987 Jul; 91(3):523-30. PubMed ID: 3038241
[TBL] [Abstract][Full Text] [Related]
10. Gastric effects of mu-, delta- and kappa-opioid receptor agonists on brainstem unitary responses in the neonatal rat.
Yuan CS
Eur J Pharmacol; 1996 Oct; 314(1-2):27-32. PubMed ID: 8957215
[TBL] [Abstract][Full Text] [Related]
11. Opioid receptor ligands in the neonatal rat spinal cord: binding and in vitro depression of the nociceptive responses.
James IF; Bettaney J; Perkins MN; Ketchum SB; Dray A
Br J Pharmacol; 1990 Mar; 99(3):503-8. PubMed ID: 2158845
[TBL] [Abstract][Full Text] [Related]
12. Opioid-receptor-mediated inhibition of [3H]dopamine but not [3H]noradrenaline release from rat mediobasal hypothalamus slices.
Heijna MH; Padt M; Hogenboom F; Schoffelmeer AN; Mulder AH
Neuroendocrinology; 1991 Aug; 54(2):118-26. PubMed ID: 1662785
[TBL] [Abstract][Full Text] [Related]
13. Peripheral opioid receptors mediating antinociception in inflammation. Evidence for involvement of mu, delta and kappa receptors.
Stein C; Millan MJ; Shippenberg TS; Peter K; Herz A
J Pharmacol Exp Ther; 1989 Mar; 248(3):1269-75. PubMed ID: 2539460
[TBL] [Abstract][Full Text] [Related]
14. Opioid receptor-mediated inhibition of evoked catecholamine release from cultured neurons of rat ventral mesencephalon and locus coeruleus.
Ronken E; Van Muiswinkel FL; Mulder AH; Schoffelmeer AN
Eur J Pharmacol; 1993 Jan; 230(3):349-55. PubMed ID: 8095023
[TBL] [Abstract][Full Text] [Related]
15. Electrophysiological demonstration of mu, delta and kappa opioid receptors in the ventral pallidum.
Mitrovic I; Napier TC
J Pharmacol Exp Ther; 1995 Mar; 272(3):1260-70. PubMed ID: 7891342
[TBL] [Abstract][Full Text] [Related]
16. Roles of central and peripheral mu, delta and kappa opioid receptors in the mediation of gastric acid secretory effects in the rat.
Fox DA; Burks TF
J Pharmacol Exp Ther; 1988 Feb; 244(2):456-62. PubMed ID: 2831341
[TBL] [Abstract][Full Text] [Related]
17. [Inhibitory effects of three opioid receptor agonists on synaptic transmission].
Yuan XR
Zhongguo Yao Li Xue Bao; 1996 May; 17(3):278-80. PubMed ID: 9812758
[TBL] [Abstract][Full Text] [Related]
18. Opioid actions on neurons of rat lateral amygdala in vitro.
Sugita S; North RA
Brain Res; 1993 May; 612(1-2):151-5. PubMed ID: 8101129
[TBL] [Abstract][Full Text] [Related]
19. Probes for narcotic receptor mediated phenomena. 17. Synthesis and evaluation of a series of trans-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]benzeneacet amide (U50,488) related isothiocyanate derivatives as opioid receptor affinity ligands.
de Costa BR; Rothman RB; Bykov V; Band L; Pert A; Jacobson AE; Rice KC
J Med Chem; 1990 Apr; 33(4):1171-6. PubMed ID: 2157008
[TBL] [Abstract][Full Text] [Related]
20. Nonopioid actions of the kappa-opioid receptor agonists, U 50488H and U 69593 on electrophysiologic properties of hippocampal CA3 neurons in vitro.
Alzheimer C; ten Bruggencate G
J Pharmacol Exp Ther; 1990 Nov; 255(2):900-5. PubMed ID: 1978733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
